Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8518
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Internal Medicine, 2021
- University Hospitals Cleveland Medical CenterInternal Medicine, 2021
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 2010 - 2013
- Kasturba Medical College ManipalClass of 2009
Certifications & Licensure
- NY State Medical License 2021 - 2026
- OH State Medical License 2013 - 2022
- IL State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Second prize in critical data hackathon (Team Award) MIT Boston, 2014
- Second prize in clinical vignette presentation at 6th annual resident research and poster day, John H. Stroger Hospital of Cook County 2011
- First in 20th zonal quiz Indian Academy of Pediatrics, 2008
- Join now to see all
Publications & Presentations
PubMed
- Obesity-Specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin.Randall J Smith Jr, Robert Zollo, Sukumar Kalvapudi, Yeshwanth Vedire, Akhil Goud Pachimatla
Journal of the National Cancer Institute. 2024-11-19 - NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi
Journal of the National Comprehensive Cancer Network. 2024-11-01 - Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?Muhammad Awidi, Angel Mier-Hicks, Stuthi Perimbeti, Kristopher Attwood, Hongbin Chen
Clinical Lung Cancer. 2024-09-01
Journal Articles
- Afatinib and Lung CancerKhunger M., Jain P., Rakshit S., Pasupuleti V., Hernandez V., Stevenson V., Jain P., Khanal R., Yan F., Sharma N.Pennell N., Velcheti V., Expert Review of Anticancer Therapy, 1/1/2014
- Isolated zinc deficiency causing severe microcytosis and sideroblastic anemiaGupta S., Jain P., Sukhal S., Turk J Haematol, 1/1/2014
- Breast cancer with brain metastases in pregnancyGupta S., Jain P., McDunn S., The Journal of Community and Supportive Oncology, 1/1/2014
- Join now to see all
Abstracts/Posters
- Prediction of response to trimodality therapy using CT derived radiomic features in locally advanced stage III non-small cell lung cancer (NSCLC)Jain P., Khorrami M., Bera K., Ahmad U., Murthy S., Stephans K., Madabhushi A., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- ERBB receptor feedback inhibitor-1 alterations in non-small cell lung cancerSchneider J., Jain P., Schalper K., Lovly C., Gardner F., Ross J., Schrock A., Ali S., Miller V., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- Efficacy of PD-1/PD- L1 inhibitors in the front-line setting as compared to previously treated patientsJain P., Khunger M., Pasupuleti V., Hernandez A., Velcheti V., J Clin Oncol, 1/1/2017
- Join now to see all
Professional Memberships
- Associate
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: